Table 2.
Coronary Angiography
| Parameter | STEMI (n=305) | NSTEMI (n=461) | P Value |
|---|---|---|---|
| Coronary anatomy | |||
| 1‐VD | 13 (4.3) | 10 (2.2) | 0.098 |
| 2‐VD | 47 (15.5) | 49 (10.7) | 0.052 |
| 3‐VD | 243 (80.2) | 397 (86.9) | 0.014 |
| LM stenosis | 115 (38.1) | 180 (40.2) | 0.564 |
| LM thrombosis | 9 (3.0) | 8 (1.8) | 0.261 |
| LM dissection | 13 (4.3) | 14 (3.1) | 0.376 |
| PCI | 62 (20.3) | 36 (7.8) | <0.001 |
| Successful but incomplete revascularization | 17 (27.4) | 4 (11.1) | 0.080 |
| Failure | 28 (45.1) | 18 (50.0) | 0.679 |
| Complication | 17 (27.4) | 13 (36.1) | 0.375 |
| Stent implantation | |||
| DES | 10 (3.3) | 2 (0.4) | 0.002 |
| BMS | 8 (2.6) | 3 (0.65) | 0.031 |
| Other/unknown | 2 (0.7) | 0 (0) | 0.1572 |
| Medication | |||
| Acetylsalicylic acid and clopidogrel | 73 (24.2) | 142 (31.9) | 0.022 |
| Ticagrelor | 5 (1.7) | 21 (4.7) | 0.028 |
| GP IIb/IIIa antagonist | 95 (31.5) | 95 (20.9) | 0.001 |
Values are expressed as count (percentage). BMS indicates bare metal stent; DES, drug‐eluting stent; GP, glycoprotein; LM, left main; NSTEMI, non–ST‐segment–elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST‐segment–elevation myocardial infarction; VD, vessel disease.